Wang R L
Tumor Department, First Affiliated Hospital of Henan Medical University, Zhengzhou.
Zhonghua Zhong Liu Za Zhi. 1993 Jul;15(4):300-2.
From August 1974 to January 1987, 650 cases of moderately and advanced esophageal carcinoma were treated with a combination of chemotherapy and Rabdosia rubescens or Rabdosia rubescens and/or tradition chinese medicinal prescription. After treatment, 40 patients survived for over 5 years (5-year survival rate 6.15%): 32 for over 6 years, 23 for more than 10 years, 5 for more than 15 years and 20 die of tumors (16 cases) or other diseases (4 cases). There were 20 patients who are still living and some of them have been living for more than 18 years. Analyzing the data, it is believed that the age, the state of activity, the length of illness, the effectiveness of primary treatment, the multi-course extensive therapy, long-term maintenance treatment, etc, are all important factors affecting the results of drug treatment.
1974年8月至1987年1月，650例中晚期食管癌患者接受了化疗与冬凌草或冬凌草及/或中药方剂联合治疗。治疗后，40例患者存活超过5年（5年生存率6.15%）：32例超过6年，23例超过10年，5例超过15年，20例死于肿瘤（16例）或其他疾病（4例）。有20例患者仍在世，其中一些已存活超过18年。分析数据认为，年龄、活动状态、病程长短、初次治疗效果、多疗程广泛治疗、长期维持治疗等，都是影响药物治疗效果的重要因素。
